Meditation

The practice

Meditation is a class of structured attentional disciplines developed over thousands of years in traditions around the world. In its scientific register, it is studied as a trainable cognitive and affective practice — the deliberate regulation of attention, emotion, and awareness through specific, repeatable techniques. The effects on brain and behavior can be measured. The conditions under which they occur can be characterized.

What the science shows

Two decades of contemplative neuroscience have established several reasonably robust findings. Sustained practice produces measurable reductions in default-mode-network activity — the same network implicated in rumination. Attention regulation improves with practice, sometimes after as little as five days of consistent training. Emotional reactivity decreases, particularly in long-term practitioners. With sufficient practice, the brain itself shows detectable structural changes.

Where the evidence is modest

Meditation's effects are real, but narrower than most marketing suggests. The most comprehensive meta-analysis, published in JAMA Internal Medicine in 2014, found moderate effects on anxiety, depression, and pain — and no evidence that meditation outperformed other active interventions like exercise or medication. In 2018, fifteen leading contemplative neuroscientists published a critical evaluation of the field's own research, warning against hype and methodological weakness. A growing literature also acknowledges that meditation can produce adverse effects — including emotional reactivity, depersonalization, and distress — that most consumer platforms fail to disclose.

The interesting work in contemplative neuroscience is not in claiming meditation can do everything. It is in characterizing what it can do, for whom, and at what cost.

How M374 approaches it

M374's meditation program treats the practice as a subject of research rather than a product to be sold. The aim is to develop methods grounded in the specific evidence — not the general enthusiasm — of the field. The work draws on the contemporary lineage of contemplative neuroscience: Richard Davidson, Antoine Lutz, Judson Brewer, Sara Lazar, Britta Hölzel, Willoughby Britton, Yi-Yuan Tang. Our intellectual ancestor across all M374 programs is William James, whose 1902 Varieties of Religious Experience inaugurated the empirical study of contemplative states.

What this research is not

The M374 meditation program is a research and development effort. It is not a medical device, a treatment, or a substitute for professional care. Meditation can produce unexpected or distressing effects in some individuals, particularly those with a history of trauma or current psychological distress. Anyone experiencing symptoms of a mental health condition, or considering intensive practice, should consult a qualified healthcare professional before proceeding.

For the full scientific foundation — the mechanisms, the evidence, the critical appraisal, and the research agenda — read the research brief.